Shigeki Kushimoto Selected Research

Hemostatics (Antihemorrhagics)

1/2017	The impact of preinjury antithrombotic medication on hemostatic interventions in trauma patients.
1/2013	A prospective analysis of disseminated intravascular coagulation in patients with infections.
8/2011	Prospective evaluation of hemostatic abnormalities in overt DIC due to various underlying diseases.
11/2007	Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shigeki Kushimoto Research Topics

Disease

54	Sepsis (Septicemia) 05/2024 - 06/2005
32	Disseminated Intravascular Coagulation 05/2024 - 03/2006
25	Wounds and Injuries (Trauma) 01/2024 - 01/2007
16	Hemorrhage 02/2024 - 01/2003
14	Septic Shock (Toxic Shock Syndrome) 01/2023 - 06/2007
13	Infections 04/2023 - 09/2012
11	Thrombosis (Thrombus) 11/2019 - 03/2006
7	COVID-19 01/2024 - 01/2021
7	Out-of-Hospital Cardiac Arrest 01/2024 - 07/2012
7	Multiple Organ Failure (MODS) 01/2022 - 03/2009
6	Hypothermia 05/2020 - 11/2013
6	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 02/2018 - 06/2007
6	Inflammation (Inflammations) 12/2016 - 06/2007
5	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 05/2024 - 06/2005
5	Thrombocytopenia (Thrombopenia) 11/2023 - 10/2007
5	Poisoning 10/2017 - 07/2006
4	Traumatic Brain Injuries (Traumatic Brain Injury) 09/2021 - 01/2011
4	Communicable Diseases (Infectious Diseases) 08/2011 - 06/2005
3	Hematoma 08/2023 - 01/2003
3	Pneumonia (Pneumonitis) 11/2022 - 08/2011
3	Critical Illness (Critically Ill) 10/2016 - 06/2007
3	Burns 11/2014 - 08/2011
3	Bacterial Infections (Bacterial Infection) 02/2011 - 06/2005
3	Ischemia 01/2011 - 09/2002
2	Hypoxia (Hypoxemia) 01/2024 - 10/2016
2	Tics (Tic) 12/2023 - 01/2020
2	Hypoglycemia (Reactive Hypoglycemia) 01/2023 - 01/2020
2	Hyperlactatemia 01/2023 - 10/2016
2	Heart Arrest (Cardiac Arrest) 04/2022 - 08/2015
2	Frailty 08/2021 - 01/2021
2	Heart Failure 01/2020 - 10/2017
2	Peritonitis 10/2017 - 04/2015
2	Hypotension (Low Blood Pressure) 10/2017 - 01/2017
2	Acidosis 01/2017 - 09/2016
2	Pulmonary Edema 01/2014 - 12/2012
2	Neoplasms (Cancer) 11/2012 - 08/2011
2	Craniocerebral Trauma (Head Injury) 09/2007 - 09/2002

Drug/Important Bio-Agent (IBA)

33	Dacarbazine (DIC)FDA LinkGeneric 05/2024 - 03/2006
11	AnticoagulantsIBA 05/2024 - 01/2010
7	Lactic Acid (Lactate)FDA LinkGeneric 01/2024 - 01/2011
7	ThrombomodulinIBA 01/2022 - 09/2002
7	Fibrinogen (Factor I)FDA Link 09/2019 - 01/2008
6	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2011
6	AntithrombinsIBA 01/2022 - 09/2004
6	Indicators and Reagents (Reagents)IBA 10/2016 - 06/2005
5	Anti-Bacterial Agents (Antibiotics)IBA 04/2023 - 01/2016
5	FibrinIBA 08/2022 - 09/2012
4	Proteins (Proteins, Gene)FDA Link 05/2022 - 01/2017
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2005
4	Oxygen (Dioxygen)IBA 01/2022 - 03/2013
4	Thrombin FDA Link 01/2022 - 09/2004
4	C-Reactive ProteinIBA 01/2020 - 06/2005
4	Hemostatics (Antihemorrhagics)IBA 01/2017 - 11/2007
4	ProcalcitoninIBA 02/2011 - 06/2005
3	Blood Glucose (Blood Sugar)IBA 01/2023 - 01/2015
3	EndotoxinsIBA 01/2023 - 06/2005
3	Polymyxin B (Aerosporin)FDA LinkGeneric 01/2023 - 01/2018
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 06/2007
3	fibrin fragment D (D-dimer)IBA 01/2021 - 09/2012
3	Carbon MonoxideIBA 01/2016 - 07/2006
2	Prothrombin (Factor II)IBA 02/2024 - 12/2017
2	Blood Coagulation Factors (Coagulation Factor)IBA 12/2023 - 07/2023
2	Tranexamic Acid (AMCA)FDA Link 12/2023 - 08/2022
2	Contrast MediaIBA 08/2023 - 01/2011
2	Hemoglobins (Hemoglobin)IBA 07/2023 - 07/2006
2	Messenger RNA (mRNA)IBA 05/2022 - 10/2017
2	Dexmedetomidine FDA Link 01/2022 - 01/2021
2	tocilizumab (atlizumab)FDA Link 01/2022 - 01/2021
2	baricitinibIBA 01/2022 - 01/2021
2	favipiravirIBA 01/2022 - 01/2021
2	Hypnotics and Sedatives (Sedatives)IBA 01/2022 - 01/2021
2	casirivimab and imdevimab drug combinationIBA 01/2022 - 01/2021
2	remdesivirIBA 01/2022 - 01/2021
2	formycin diphosphate (FDP)IBA 01/2021 - 08/2011
2	Complement System Proteins (Complement)IBA 05/2020 - 11/2017
2	Vitamin K FDA Link 01/2018 - 12/2017
2	diethylene glycolIBA 10/2017 - 01/2017
2	Bisoprolol (Concor)FDA LinkGeneric 10/2017 - 11/2014
2	CreatinineIBA 12/2016 - 12/2013
2	Mitochondrial DNA (mtDNA)IBA 01/2016 - 12/2013
2	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2014 - 08/2011
2	fibrinmonomerIBA 09/2012 - 08/2011
2	Pyruvic Acid (Pyruvate)IBA 11/2011 - 01/2011
2	von Willebrand FactorIBA 09/2007 - 09/2002
1	tetraethylpyrazine (TEP)IBA 11/2023

Therapy/Procedure

20	Therapeutics 05/2024 - 06/2007
15	Critical Care (Surgical Intensive Care) 01/2024 - 01/2008
12	Resuscitation 01/2024 - 07/2012
6	Artificial Respiration (Mechanical Ventilation) 01/2024 - 01/2021
5	Mechanical Ventilators (Ventilator) 04/2023 - 01/2014
4	Extracorporeal Membrane Oxygenation 01/2024 - 01/2022
4	Cardiopulmonary Resuscitation (CPR) 01/2024 - 01/2021
4	Laparotomy 04/2015 - 01/2003
3	Patient Care Bundles 01/2022 - 11/2019
2	Erythrocyte Transfusion 01/2024 - 07/2023
2	Blood Transfusion (Blood Transfusions) 08/2022 - 01/2010
2	Glycemic Control 10/2021 - 02/2014
2	Length of Stay 08/2021 - 01/2021
2	Hemoperfusion 11/2020 - 01/2018
2	Catheters 01/2016 - 08/2015